Health Economics & Policy

FDA: Immunological response of metal containing implants under scrutiny

The US FDA calls for a common engagement involving surgeons, scientists, patients and industry to collect evidence on implant materials. The goal is to develop a better understanding of materials science and the adverse...

Burden of Disease: Can the Curve Be Flattened?

The growing number of hip arthroplasty procedures requires solutions and adequate planning to reduce the future burden of disease and its economic consequences. As revision has a severe impact on the patient’s quality of life...

Hip Resurfacing: Current limitations and new solutions

Hip resurfacing with metal implants is limited by restrictive patient selection. Using ceramic components allows to eliminate metal-related issues and opens new options for this tissuesparing procedure. Thanks to the...